Drug Profile


Alternative Names: APD-209 - Acacia; Megestrol/formoterol

Latest Information Update: 07 Jan 2016

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Acacia Pharma
  • Class Ethanolamines; Pregnadienes; Small molecules
  • Mechanism of Action Beta 2 adrenergic receptor agonists; Progesterone receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Phase II Cachexia

Most Recent Events

  • 07 Jan 2016 Acacia plans clinical trials for Cachexia (Acacia website; January 2016)
  • 01 Sep 2015 Phase II development for Cachexia is ongoing in the United Kingdom
  • 06 Dec 2011 Efficacy & adverse events data from a phase IIa trial in Cachexia released by Acacia Pharma
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top